Expleo Solutions Limited EXPLEOSOL NSETECH

Technology · Information Technology Services · India

https://investors.expleo.com

Expleo Solutions Limited, together with its subsidiaries, primarily provides software validation and verification services to the banking, financial services, and insurance industries worldwide. It offers computer programming, consultancy and related activities, quality management, software development, software testing, digital transformation, product and process engineering, quality & testing, and customer support and maintenance services. It also offers financial services. The company was formerly known as SQS India BFSI Limited and changed its name to Expleo Solutions Limited in April 2019. Expleo Solutions Limited was incorporated in 1998 and is based in Chennai, India. Expleo Solutions Limited Limited is a subsidiary of Expleo Technology Germany GmbH.

Market & Price

Market Cap

₹1,356.81 Cr

Current Price

₹874.25

High / Low (52W)

₹1,333.00 / ₹646.90

Beta

0.21

Valuation

Stock P/E

10.94

Industry PE

25.13

Forward P/E

PEG Ratio

Book Value

₹500.20

Price to Book

1.75

P/S

1.22

EV/EBITDA

5.82

Dividend Yield

5.67%

Profitability & Returns

ROCE

20.58%

ROE

17.56%

ROA

10.06%

Profit Margin

11.19%

Op Margin

12.86%

EPS (Latest Qtr)

₹26.85

EPS (TTM)

₹79.91

Balance Sheet & Liquidity

Debt/Equity

1.01

Quick Ratio

4.73

Current Ratio

5.55

Debt

₹7.85 Cr

Total Assets

₹928.83 Cr

Current Assets

₹711.18 Cr

Working Capital

₹583.10 Cr

Ownership

Promoter Holding

71.05%

Chg in Prom Hold

FII / Inst Holding

0.07%

Chg in FII Hold

Financial Snapshot

Enterprise Value

₹988.90 Cr

Total Revenue (TTM)

₹1,107.96 Cr

EBITDA

₹169.97 Cr

Free Cash Flow

₹110.71 Cr

Operating Cash Flow

₹119.47 Cr

Shares Outstanding

₹1.55 Cr

Gross Margin

36.40%

Payout Ratio

0.00%

Growth (CAGR)

Revenue 5Y

7.04%

Profit 5Y

-2.53%

Revenue (YoY)

11.90%

Earnings (YoY)

73.20%

PROS

Healthy ROCE of 20.6%.
Attractive dividend yield of 5.67%.
Generates positive free cash flow.

CONS

Earnings shrank at -2.5% CAGR over 5 years.
Trading 34.4% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView Screener.in

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Technology).

#	Name	CMP ₹	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	EXPLEOSOL Expleo Solutions Limited NSETECH	874.25	10.94	₹1,356.81 Cr	5.67%	20.58%	17.56%	7.04%	-2.53%
2	TCS Tata Consultancy Services Limited NIFTY50NSEAITECH	2,258.90	16.61	₹8.17 L Cr	5.49%	54.93%	48.40%	5.80%	5.30%
3	INFY Infosys Limited NIFTY50NSEAITECH	1,160.90	15.01	₹4.70 L Cr	4.31%	41.66%	31.44%	3.44%	3.58%
4	HCLTECH HCL Technologies Limited NIFTY50NSEAITECH	1,183.80	19.31	₹3.20 L Cr	8.11%	27.21%	23.36%	8.65%	3.87%
5	WIPRO Wipro Limited NIFTY50NSEAITECH	204.25	16.26	₹2.14 L Cr	8.32%	18.42%	15.49%	4.05%	2.44%
6	TECHM Tech Mahindra Limited NIFTY50NSEAITECH	1,483.90	27.40	₹1.31 L Cr	3.44%	20.60%	16.61%	2.16%	-0.14%
7	LTM LTM Limited NSETECH	4,061.60	24.04	₹1.20 L Cr	1.85%	25.39%	21.29%	8.43%	4.41%
8	LGEINDIA LG ELECTRONICS INDIA LTD NIFTY_MIDNSETECH	1,523.90	61.35	₹1.03 L Cr	-	27.64%	24.72%	0.98%	-
9	WAAREEENER WAAREE ENERGIES LIMITED NIFTY_MIDNSETECH	3,140.80	27.70	₹90,345.53 Cr	0.13%	24.21%	31.57%	71.63%	191.18%

Quarterly Results

Figures in INR.

Metric	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	255.80 Cr	259.65 Cr	282.69 Cr	279.35 Cr	286.27 Cr
Cost of Revenue	-	162.59 Cr	166.35 Cr	177.75 Cr	172.52 Cr	188.02 Cr
Gross Profit	-	93.20 Cr	93.30 Cr	104.95 Cr	106.82 Cr	98.26 Cr
Operating Expenses	-	61.25 Cr	71.24 Cr	7.44 Cr	68.06 Cr	61.44 Cr
Operating Income	-	31.95 Cr	22.05 Cr	97.51 Cr	38.77 Cr	36.82 Cr
EBITDA	-	44.52 Cr	36.67 Cr	59.41 Cr	39.67 Cr	57.37 Cr
Interest Expense	-	94.00 L	64.10 L	59.90 L	42.20 L	57.30 L
Pretax Income	-	35.52 Cr	28.36 Cr	51.38 Cr	31.95 Cr	50.88 Cr
Tax Provision	-	11.45 Cr	7.93 Cr	11.62 Cr	9.82 Cr	9.21 Cr
Net Income	-	24.08 Cr	20.43 Cr	39.76 Cr	22.13 Cr	41.67 Cr
Diluted EPS	-	15.51	13.16	25.62	14.26	26.85

Profit & Loss (Annual)

Figures in INR.

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Revenue	-	903.29 Cr	964.87 Cr	1,024.80 Cr	1,107.96 Cr
Cost of Revenue	-	458.92 Cr	547.67 Cr	615.34 Cr	704.64 Cr
Gross Profit	-	444.37 Cr	417.20 Cr	409.46 Cr	403.32 Cr
Operating Expenses	-	271.05 Cr	302.31 Cr	281.20 Cr	261.69 Cr
Operating Income	-	173.33 Cr	114.88 Cr	128.26 Cr	141.64 Cr
EBITDA	-	216.25 Cr	155.85 Cr	181.87 Cr	193.13 Cr
Interest Expense	-	2.26 Cr	2.61 Cr	3.32 Cr	2.23 Cr
Pretax Income	-	186.11 Cr	119.57 Cr	139.24 Cr	162.56 Cr
Tax Provision	-	52.22 Cr	29.14 Cr	36.00 Cr	38.58 Cr
Net Income	-	133.89 Cr	90.44 Cr	103.24 Cr	123.98 Cr
Diluted EPS	-	86.27	58.27	66.52	79.89

Compounded Sales Growth

5 Years:	7.04%
1 Year:	11.90%

Compounded Profit Growth

5 Years:	-2.53%
1 Year:	73.20%

Stock Price Performance

1 Year:	-14.95%
6 Months:	-21.48%
3 Months:	+5.44%
1 Month:	+7.38%

Balance Sheet (Annual)

Figures in INR.

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Total Assets	-	730.23 Cr	764.75 Cr	831.08 Cr	928.83 Cr
Current Assets	-	552.79 Cr	597.70 Cr	563.16 Cr	711.18 Cr
Cash & Equivalents	-	152.53 Cr	176.14 Cr	217.49 Cr	354.25 Cr
Inventory	2.27 Cr	0	-	-	-
Receivables	-	239.41 Cr	249.36 Cr	222.30 Cr	229.56 Cr
Total Liabilities	-	200.00 Cr	153.60 Cr	195.23 Cr	152.51 Cr
Current Liabilities	-	167.74 Cr	103.62 Cr	144.46 Cr	128.08 Cr
Long Term Debt	45.70 L	39.30 L	0	-	-
Total Debt	-	26.26 Cr	26.06 Cr	29.80 Cr	7.85 Cr
Total Equity	-	530.23 Cr	611.15 Cr	635.84 Cr	776.31 Cr
Shares Outstanding	-	1.03 Cr	1.55 Cr	1.55 Cr	1.55 Cr

Cash Flows (Annual)

Figures in INR.

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow	-	23.08 Cr	71.35 Cr	179.42 Cr	119.47 Cr
Investing Cash Flow	-	-35.99 Cr	-31.32 Cr	-53.16 Cr	31.87 Cr
Financing Cash Flow	-	-6.57 Cr	-15.20 Cr	-87.10 Cr	-9.46 Cr
Capital Expenditure	-	-44.20 Cr	-17.48 Cr	-7.92 Cr	-2.96 Cr
Free Cash Flow	-	-21.11 Cr	53.86 Cr	171.50 Cr	116.50 Cr
Net Change in Cash	-	-19.48 Cr	24.82 Cr	39.16 Cr	141.88 Cr

Ratios (Annual)

Figures in %.

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Gross Margin %	-	49.2%	43.2%	40.0%	36.4%
Operating Margin %	-	19.2%	11.9%	12.5%	12.8%
Net Margin %	-	14.8%	9.4%	10.1%	11.2%
ROE %	-	25.3%	14.8%	16.2%	16.0%
ROCE %	-	30.8%	17.4%	18.7%	17.7%

Shareholding Pattern

Insiders

71.05%

Institutions

0.07%

Public Float

0.24%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for EXPLEOSOL

No recent headlines available.

EXPLEOSOL · Technology